Holen Sie sich die Stockscreener-App
6.03
0.33%
0.02
Handel nachbörslich:
6.03
Diamedica Therapeutics Inc Aktie (DMAC) Neueste Nachrichten
Identifying reversal signals in DiaMedica Therapeutics Inc.2025 Investor Takeaways & Verified Momentum Stock Alerts - Newser
DiaMedica Therapeutics Inc (DMAC) Stock: 52-Week Performance Insights and Trading Volume - investchronicle.com
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q2 2025 Earnings Call Transcript - Insider Monkey
Will DiaMedica Therapeutics Inc. see short term momentumEarnings Risk Report & Fast Entry High Yield Stock Tips - Newser
DiaMedica advances DM199 programs with $60M cash runway and expanded clinical trials - MSN
Statistical indicators supporting DiaMedica Therapeutics Inc.’s strengthJuly 2025 Closing Moves & Safe Entry Zone Tips - Newser
DiaMedica Therapeutics Advances with Positive Trials and Funding - TipRanks
Technical analysis overview for DiaMedica Therapeutics Inc. stockJuly 2025 Closing Moves & Weekly Market Pulse Alerts - Newser
Intrinsic Value of DiaMedica Therapeutics Inc. Stock: Is It Undervalued or OvervaluedShare Buyback & Real-Time Buy Signal Notifications - Newser
DiaMedica Therapeutics reports Q2 EPS (18c), consensus (19c) - MSN
DiaMedica: Interim Results Brings Study Expansions For DM199 In Preeclampsia (NASDAQ:DMAC) - Seeking Alpha
Diamedica Therapeutics shares rise 14.94% intraday after Celcuity's positive Phase 3 trial results. - AInvest
DiaMedica Therapeutics Q2 2025 Earnings Call Transcript - MarketBeat
Diamedica Therapeutics shares rise 1.92% intraday after Q2 2025 earnings call. - AInvest
Earnings call transcript: DiaMedica Therapeutics Q2 2025 shows promising trials By Investing.com - Investing.com South Africa
Earnings call transcript: DiaMedica Therapeutics Q2 2025 shows promising trials - Investing.com India
What to expect from DiaMedica Therapeutics Inc. in the next 30 daysWeekly Market Summary & Expert Approved Momentum Ideas - Newser
Pattern recognition hints at DiaMedica Therapeutics Inc. upside2025 Trade Ideas & Fast Gain Stock Tips - Newser
Technical signs of recovery in DiaMedica Therapeutics Inc.Weekly Investment Report & Free Reliable Trade Execution Plans - Newser
DiaMedica Posts Narrower Loss in Q2 - AOL.com
What indicators show strength in DiaMedica Therapeutics Inc. [Short Setup]Weekly Top Gainers Trade List - Newser
DiaMedica Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights - BioSpace
Full technical analysis of DiaMedica Therapeutics Inc. stockAI Intraday Market Movement Prediction Tool - Newser
DiaMedica Therapeutics Enters Sales Agreement with TD Securities - TipRanks
Is this a good reentry point in DiaMedica Therapeutics Inc.Fast Entry Strategy with Price Prediction - Newser
DiaMedica Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Can DiaMedica Therapeutics Inc. sustain its profitabilityReal-Time Trade Breakout Scanner - thegnnews.com
Screener Results Flag DiaMedica Therapeutics Inc. as OversoldROI Driven Equity Selection With Safety Emphasized - 선데이타임즈
What data driven models say about DiaMedica Therapeutics Inc.’s futureRapid Trade Forecast Based on Indicators - Newser
Momentum divergence signals in DiaMedica Therapeutics Inc. chartAutomated AI Forecast with Trading Alerts - Newser
Fair Value Estimate for DiaMedica Therapeutics: $5.11; Share Price Matches Fair Value; Analyst Price Target Exceeds Fair Value. - AInvest
Volume spikes in DiaMedica Therapeutics Inc. stock – what they meanShort-Term AI-Based Stock Price Forecast - Newser
What’s the recovery path for long term holders of DiaMedica Therapeutics Inc. - Newser
What makes DiaMedica Therapeutics Inc. stock price move sharplyFree AI Based High Gain Watchlist Scanner - Newser
Press Release: DiaMedica Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update August 13, 2025 - 富途牛牛
Can momentum traders help lift DiaMedica Therapeutics Inc.Free Low Risk Buy Zone Opportunity Watch - Newser
DiaMedica Therapeutics Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
What indicators show strength in DiaMedica Therapeutics Inc.Conservative Equity Setup with Signal Analysis - Newser
DiaMedica Therapeutics appoints Julie Krop as Chief Medical Officer - MSN
DiaMedica Appoints New Chief Medical Officer - The Globe and Mail
Intraday pattern recognizer results for DiaMedica Therapeutics Inc.Swing Entry Insight With Forecast Accuracy - Newser
Diamedica Therapeutics shares rise 3.12% intraday after appointing Julie Krop, MD, as Chief Medical Officer. - AInvest
DiaMedica Therapeutics Appoints Julie Krop, MD, as Chief Medical Officer. - AInvest
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):